1 |
VALDERRAMA-TREVIÑO A I, BARRERA-MERA B, CEBALLOS-VILLALVA J C, et al. Hepatic metastasis from colorectal cancer[J]. Euroasian J Hepatogastroenterol, 2017, 7(2):166-175.
|
2 |
PADMANABHAN C, NUSSBAUM D P, D'ANGELICA M. Surgical management of colorectal cancer liver metastases[J]. Surg Oncol Clin N Am, 2021, 30(1):1-25.
DOI
PMID
|
3 |
KUAI L, ZHANG Y, LUO Y, et al. Prognostic nomogram for liver metastatic colon cancer based on histological type,tumor differentiation,and tumor deposit:a TRIPOD compliant large-scale survival study[J]. Front Oncol, 2021, 11:604882.
DOI
URL
|
4 |
叶青, 朱建勇, 张立波, 等. 血清白细胞介素-6、触珠蛋白及淀粉样蛋白A对慢性阻塞性肺疾病患者肺部感染的鉴别诊断研究[J]. 中华医院感染学杂志, 2017, 27(13):2961-2964.
|
5 |
MORISHITA K, ITO N, KODA S, et al. Haptoglobin phenotype is a critical factor in the use of fucosylated haptoglobin for pancreatic cancer diagnosis[J]. Clin Chim Acta, 2018, 487:84-89.
DOI
PMID
|
6 |
FUJITA K, SHIMOMURA M, UEMURA M, et al. Serum fucosylated haptoglobin as a novel prognostic biomarker predicting high-Gleason prostate cancer[J]. Prostate, 2014, 74(10):1052-1058.
DOI
PMID
|
7 |
BROWN R A M, RICHARDSON K L, KABIR T D, et al. Altered iron metabolism and impact in cancer biology,metastasis,and immunology[J]. Front Oncol, 2020, 10:476.
DOI
URL
|
8 |
CHIBAUDEL B, MAINDRAULT-GOEBEL F, LLEDO G, et al. Can chemotherapy be discontinued in unresectable metastatic colorectal cancer? The GERCOR OPTIMOX2 Study[J]. J Clin Oncol, 2009, 27(34):5727-5733.
DOI
PMID
|
9 |
FENG Z, CHEN J W, FENG J H, et al. The association between serum ferritin with colorectal cancer[J]. Int J Clin Exp Med, 2015, 8(12):22293-22299.
PMID
|
10 |
GIESSEN-JUNG C, NAGEL D, GLAS M, et al. Preoperative serum markers for individual patient prognosis in stage Ⅰ-Ⅲ colon cancer[J]. Tumour Biol, 2015, 36(10):7897-7906.
DOI
URL
|
11 |
LI F, KISHIDA T, KOBAYASHI M. Serum iron and ferritin levels in patients with colorectal cancer in relation to the size,site,and disease stage of cancer[J]. J Gastroenterol, 1999, 34(2):195-199.
DOI
URL
|
12 |
LEE S, SONG A, EO W. Serum ferritin as a prognostic biomarker for survival in relapsed or refractory metastatic colorectal cancer[J]. J Cancer, 2016, 7(8):957-964.
DOI
PMID
|
13 |
SUN L, PAN J, PENG L, et al. Combination of haptoglobin and osteopontin could predict colorectal cancer hepatic metastasis[J]. Ann Surg Oncol, 2012, 19(7):2411-2419.
DOI
PMID
|
14 |
SUN L, HU S, YU L, et al. Serum haptoglobin as a novel molecular biomarker predicting colorectal cancer hepatic metastasis[J]. Int J Cancer, 2016, 138(11):2724-2731.
DOI
PMID
|
15 |
蒋志强, 李亚兰, 韩广森, 等. 术前血清白蛋白水平与结肠癌临床病理特征及生存预后的关系[J]. 中华胃肠外科杂志, 2016, 19(1):80-83.
|
16 |
HAMILTON T D, LEUGNER D, KOPCIUK K, et al. Identification of prognostic inflammatory factors in colorectal liver metastases[J]. BMC Cancer, 2014, 14:542.
DOI
PMID
|